NEW YORK (GenomeWeb News) – Interleukin Genetics' fourth-quarter revenues dropped 41 percent year over year, the company reported after the close of the market on Thursday, adding it has enough financial resources to last only through next month.

Revenues for the three months ended Dec. 31, 2012 totaled $339,057, down from $575,339 a year ago. Interleukin attributed the drop to decreased genetic testing revenue resulting from sales through the Amway Global sales channel.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.